On Invalid Date, Novartis Ag (NYSE: NVS) reported Q1 2024 earnings per share (EPS) of $1.31, up 20.18% year over year. Total Novartis Ag earnings for the quarter were $2.69 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $1.09.
As of Q2 2024, Novartis Ag's earnings has grown 125.91% year over year. This is 106.29 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 19.62%. Novartis Ag's earnings in the past year totalled $15.25 billion.
What is NVS's earnings date?
Novartis Ag's earnings date is Invalid Date. Add NVS to your watchlist to be reminded of NVS's next earnings announcement.
What was NVS's revenue last quarter?
On Invalid Date, Novartis Ag (NYSE: NVS) reported Q1 2024 revenue of $12.12 billion up 9.71% year over year. In the same quarter last year, Novartis Ag's revenue was $11.05 billion.
What was NVS's revenue growth in the past year?
As of Q2 2024, Novartis Ag's revenue has grown 8.81% year over year. This is 0.03 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 8.85%. Novartis Ag's revenue in the past year totalled $49.92 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.